hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 20:06:14 - browse：5

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： The boys, now 6, who are gene therapy’s ‘edge case’ problem

entertainment

leisure time

WSS

Clinical trials must include more disabled people

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

The pain doctors face in trying to build their families

Digital health: a case of mistaken identity

Listen: Racing for gene therapy & a pioneering approval

Liver decline slowed by off

hotspot

hotspot

entertainment

Guidelines to prevent youth baseball injuries need more muscle

For longer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Digital health: a case of mistaken identity

What does generative AI mean for health care? We asked experts

Beware the threat of staffing cuts at the CDC

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

How one medical school became remarkably diverse

Eyeing GLP

explore

ASCO eve: Let’s set the table for this year's meeting

Liver decline slowed by off

Bird flu surveillance in wastewater gets boost from consortium

Listen: Racing for gene therapy & a pioneering approval

Eyeing GLP

Eyeing GLP

entertainment

leisure time

focus

focus